Case report A self employed decorator developed his first attack of gout, affecting his first metatarsophalangeal (MTP) joint, at age 40. Risk factors were regular beer drinking and a family history of gout in his father; he had no history of urolithiasis, was not obese, and his blood pressure was normal. His general practitioner diagnosed classic podagra, confirmed an increased serum uric acid concentration of 540 imol/l (normal range in males 100-400 pimol/l), and advised reduction of beer intake.
Despite elimination of beer drinking, the patient suffered increasingly frequent attacks of podagra and was therefore started on allopurinol 300 mg daily. This reduced his attack frequency and brought his serum uric acid concentration into the normal range. However, over subsequent years he continued to experience attacks (up to six per year) affecting both midtarsal and ankle joints, in addition to first MTP joints. His serum urate concentration was checked on several occasions and found to be normal; his allopurinol dose was therefore not altered.
At age 55 the patient was admitted to hospital with an uncomplicated acute anterolateral myocardial infarction. He had never smoked. He was given thrombolytic therapy and analgesics. On day 3, however, he developed acute florid synovitis with overlying erythema of his left knee. Aspiration yielded 80 ml of turbid fluid; monosodium urate crystals were identified by compensated polarised microscopy; gram stain and culture were negative. His gout attack quickly settled following intra-articular injection of steroid and he was rapidly mobilised. At clinic review six weeks later, his serum urate concentration was 350 ,umol/l and a spot urinary uric acid:creatinine ratio supported undersecretor status (that is, it was <0.5); serum concentrations of urea and creatinine, haemoglobin and random glucose concentrations and urine analysis were all normal. His dose of allopurinol was increased to 400 mg in the first instance and he was reviewed six weekly with repeat serum urate estimations. Investigation of fasting lipids and lipoproteins (three months after discharge) revealed markedly increased triglyceride concentrations (6 1 mmol/l), mildly increased cholesterol (6-6 mmol/l) and low HDL-cholesterol. This improved with dietary advice and subsequently by addition of bezafibrate (an isobutyric acid derivative). On a greater allopurinol dose (500 mg daily), his serum urate concentration was maintained less than 250 limol/l. The frequency of acute attacks gradually diminished and over the past year he has had only one minor episode.
Discussion RISK FACTORS AND ASSOCIATIONS
At the time of initial diagnosis of gout, both risk factors and disease associations merit consideration and appropriate screening.' This man had the common form of 'primary' gout presenting around middle age and relating to renal undersecretion, rather than primary overproduction, of uric acid. There was no chronic use of diuretic drugs or renal impairment to suggest 'secondary' gout. Principal correctable risk factors in men with primary gout are obesity and excess alcohol (especially beer) intake.2 Hypertension, hypertriglyceridaemia (especially type IV lipoproteinaemia), and ischaemic heart disease are important disease associations2-4 (though hyperuricaemia itself is not an independent risk factor for atherosclerosis). In this non-obese patient, excessive beer intake was correctly identified and addressed. His practitioner checked his blood pressure, but omitted to screen for uric acid overproduction (< 15% of primary gout), renal impairment, or an abnormal lipoprotein profile (present in about 30-75% of men with primary gout2). The opportunity was therefore missed for early detection and primary prevention of a major (in this patient the only) correctable risk factor for cardiovascular disease. TREATMENT 
